Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,277-3,288 of 4,306
Drug study icon
CompletedEUCTR 2022-001865-11

A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study with an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy, Safety, and Tolerability of Ola...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Bulgaria
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2022-000580-52

A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses (10 mg and 30 mg QD) of CVL-231 in Participants With Schizophreni...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Bulgaria
Sponsor
Cerevel Therapeutics, LLC
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2022-000581-17

A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses (15 mg and 30 mg QD) of CVL-231 in Participants With Schizophreni...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Bulgaria, Hungary
Sponsor
Cerevel Therapeutics, LLC
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2005-006048-42

A Phase 2a, Multiple-Dose, Placebo Controlled, Randomized, Two Way Crossover Study to Assess the Efficacy of SCH 420814 in Reducing Anti-Psychotic-Induced Extra-Pyramidal Symptoms Among Subjects Wi...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany
Sponsor
Schering-Plough Research Institute
Condition
Schizophrenia
Drug study icon
Active Not RecruitingEUCTR 2017-002406-12

HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medicati...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Groningen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Netherlands
Sponsor
University Medical Center Groningen
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2009-015629-35

Open-label, single arm, interventional study to explore the efficacy and safety of paliperidone ER in the management of patients with acute agitation and/or aggression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Belgium
Sponsor
Janssen-Cilag NV/SA
Condition
Schizophrenia
Drug study icon
TerminatedEUCTR 2017-003705-17

Prevention of neuropsychiatric adverse effects caused by dexamethasone: translational insights from a placebo-controlled trial with hydrocortisone.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Depression, ...Drug
Countries
Netherlands
Sponsor
LUMC
Condition
Schizophrenia, Depression, ...
Drug study icon
TerminatedEUCTR 2011-004826-87

Randomized multicentric open-label phase III clinical trial to evaluate the efficacy of continual treatment versus discontinuation based in the presence of prodromes in a first episode of non-affe...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Spain
Sponsor
Fundacion Progreso y Salud
Condition
Schizophrenia
Drug study icon
Recruitment unclearEUCTR 2012-004546-15

Assessment of incidence of adverse events in a naive pediatric population treated with an antipsychotic drug over 12 months follow-up

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
France
Sponsor
CHU de Nice
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN29242879

Cognitive behavioural treatment for persistent positive symptoms in psychotic disorders

This study is looking at whether Cognitive Behavioural Treatment versus Supportive Therapy can help people with psychosis or Mental and Behavioural Disorders. Participants take part in Cognitive Behavioural Treatment versus Supportive Therapy and complete follow-up assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
Germany
Sponsor
University Hospital Tuebingen (Germany)
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN42478021

Combined individual and family cognitive behavioural therapy compared with treatment as usual

This study is looking at how cognitive behavioural therapy works for people with Specialty: Mental Health, Primary sub-specialty: Psychosis, UKCRC code/ Disease: Mental Health/ Organic, including symptomatic, mental disorders, Mental and Behavioural Disorders, or Psychosis in routine care. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Greater Manchester West Mental Health NHS Foundation Trust
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.